A Safety and Effectiveness Study of TMC435 in Chronic, Genotype 1, Hepatitis C Patients Who Failed to Previous Standard Treatment
Clinical trial NCT00980330 · COMPLETED
Trial details
- NCT number
- NCT00980330
- Sponsor
- Tibotec Pharmaceuticals, Ireland
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2011-08-01
- Enrollment
- 463
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.